Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.
Gartzen
K
K
Limmroth
V
V
Putzki
N
N
D002574:Cervical Vertebrae / Q000187:drug effects / Q000473:pathology; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D009471:Neuromyelitis Optica / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D010455:Peptides / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate